Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joseph, E.
Right arrow Articles by Reintgen, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joseph, E.
Right arrow Articles by Reintgen, D. S.

Annals of Surgical Oncology, Vol 5, Issue 2 119-125, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes

E. Joseph, A. Brobeil, F. Glass, J. Glass, J. Messina, R. DeConti, C. W. Cruse, D. P. Rapaport, C. Berman, N. Fenske and D. S. Reintgen
The Cutaneous Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa 33612-9497, USA.

BACKGROUND: The technique of sentinel lymph node (SLN) biopsy for melanoma provides accurate staging information because the histology of the SLN reflects the histology of the entire basin, particularly when the SLN is negative. METHODS: We combined two mapping techniques, one using vital blue dye and the other using radiolymphoscintigraphy with a hand-held gamma Neoprobe, to identify the SLN in 600 consecutive patients with stage I-II melanoma. The SLNs were examined using conventional histopathology and immunohistochemistry for S-100. RESULTS: Eighty-three (13.9%) patients had micrometastatic disease in the SLNs. Thirty percent of patients with primary melanomas greater than 4.0 mm in thickness had positive SLNs, followed by 48 of 267 (18%) of patients with tumors between 1.5 mm and 4 mm, and 12 of 169 (7%) of those with lesions between 1.0 mm and 1.5 mm. No patient with a tumor less than 0.76 mm in thickness had a positive SLN. Sixty-four of the 83 SLN-positive patients consented to undergo complete lymph node dissection (CLND), and five of 64 (7.8%) of the CLNDs were positive. All patients with positive CLNDs had tumor thicknesses greater than 3.0 mm. CONCLUSIONS: The rate of SLN-positive patients increases with increasing thickness of the melanoma. SLN-positive patients with primary lesions less than 1.5 mm in thickness may have disease confined to the SLN, thus rendering higher-level nodes free of disease, and may not require a CLND.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
C. R. Rossi, G. L. De Salvo, E. Bonandini, S. Mocellin, M. Foletto, S. Pasquali, P. Pilati, M. Lise, D. Nitti, E. Rizzo, et al.
Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node
Ann. Surg. Oncol., April 1, 2008; 15(4): 1202 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
G. C. Karakousis, P. A. Gimotty, J. D. Botbyl, S. B. Kesmodel, D. E. Elder, R. Elenitsas, M. E. Ming, D. Guerry, D. L. Fraker, B. J. Czerniecki, et al.
Predictors of Regional Nodal Disease in Patients With Thin Melanomas
Ann. Surg. Oncol., April 1, 2006; 13(4): 533 - 541.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. B. Kesmodel, G. C. Karakousis, J. D. Botbyl, R. J. Canter, R. T. Lewis, P. M. Wahl, K. P. Terhune, A. Alavi, D. E. Elder, M. E. Ming, et al.
Mitotic Rate as a Predictor of Sentinel Lymph Node Positivity in Patients With Thin Melanomas
Ann. Surg. Oncol., June 1, 2005; 12(6): 449 - 458.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. H. Lee, R. Essner, H. Torisu-Itakura, L. Wanek, H. Wang, and D. L. Morton
Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for Melanoma
J. Clin. Oncol., September 15, 2004; 22(18): 3677 - 3684.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
V. K. Sondak, J. M. G. Taylor, M. S. Sabel, Y. Wang, L. Lowe, A. C. Grover, A. E. Chang, A. M. Yahanda, J. Moon, and T. M. Johnson
Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model
Ann. Surg. Oncol., March 1, 2004; 11(3): 247 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. A. Pockaj, D. E. Jaroszewski, D. J. DiCaudo, J. G. Hentz, E. W. Buchel, R. J. Gray, S. N. Markovic, and U. Bite
Changing Surgical Therapy for Melanoma of the External Ear
Ann. Surg. Oncol., July 1, 2003; 10(6): 689 - 696.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
G. W. Carlson, D. R. Murray, R. H. Lyles, C. A. Staley, A. Hestley, and C. Cohen
The Amount of Metastatic Melanoma in a Sentinel Lymph Node: Does It Have Prognostic Significance?
Ann. Surg. Oncol., June 1, 2003; 10(5): 575 - 581.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
J. B. Lowe, E. Hurst, J. F. Moley, and L. A. Cornelius
Sentinel Lymph Node Biopsy in Patients With Thin Melanoma
Arch Dermatol, May 1, 2003; 139(5): 617 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
C. E. Schmalbach, B. Nussenbaum, R. S. Rees, J. Schwartz, T. M. Johnson, and C. R. Bradford
Reliability of Sentinel Lymph Node Mapping With Biopsy for Head and Neck Cutaneous Melanoma
Arch Otolaryngol Head Neck Surg, January 1, 2003; 129(1): 61 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. M. Ranieri, J. D. Wagner, R. Azuaje, D. Davidson, S. Wenck, J. Fyffe, and J. J. Coleman III
Prognostic Importance of Lymph Node Tumor Burden in Melanoma Patients Staged by Sentinel Node Biopsy
Ann. Surg. Oncol., December 1, 2002; 9(10): 975 - 981.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. M. McMasters, S. L. Wong, M. J. Edwards, C. Chao, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and D. S. Reintgen
Frequency of Nonsentinel Lymph Node Metastasis in Melanoma
Ann. Surg. Oncol., March 1, 2002; 9(2): 137 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
R. W. Dubois, S. M. Swetter, M. Atkins, K. McMasters, R. Halbert, S. J. Miller, R. Shiell, and J. Kirkwood
Developing Indications for the Use of Sentinel Lymph Node Biopsy and Adjuvant High-Dose Interferon Alfa-2b in Melanoma
Arch Dermatol, September 1, 2001; 137(9): 1217 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. D. Wagner, H.-M. Park, J. J. Coleman III, C. Love, and J. T. Hayes
Cervical Sentinel Lymph Node Biopsy for Melanomas of the Head and Neck and Upper Thorax
Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 313 - 321.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
U. Veronesi, G. Paganelli, G. Viale, V. Galimberti, A. Luini, S. Zurrida, C. Robertson, V. Sacchini, P. Veronesi, E. Orvieto, et al.
Sentinel Lymph Node Biopsy and Axillary Dissection in Breast Cancer: Results in a Large Series
J Natl Cancer Inst, February 17, 1999; 91(4): 368 - 373.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. N. Myers
Value of Neck Dissection in the Treatment of Patients With Intermediate-Thickness Cutaneous Malignant Melanoma of the Head and Neck
Arch Otolaryngol Head Neck Surg, January 1, 1999; 125(1): 110 - 115.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society of Surgical Oncology.